BP Comment Quick Links
![]() |
|
|
The First-ever Baseball Prospectus Futures Guide - now just $7.00 at Amazon ( bbp.cx/fg ) |
|
|
February 9, 2010 Team Health ReportsFlorida Marlins
The Summary: Even three years later, almost everything in the injury stats for the Marlins can be traced back to Joe Girardi. Girardi's ring was paid for with the experience the skipper had abusing young pitchers during his Marlins tenure. While Josh Johnson has come all the way back, the same can't be said for almost everyone else. Luckily, the team not only stays cheap, they focus on quantity, which has saved them many times. A combination of solid scouting, development, and an understanding that avoiding replacement level for the right value has been a key part of the team's success. The medical staff hasn't had much of a chance to shine, though they certainly deserve some of the blame for falling down on the prevention watch. The Marlins also serve as a reminder that young players actually get hurt more than old ones. They just heal faster.
The Facts The Cost: Injuries only cost the Marlins $3.5 million last year and $11.4 million the last three years. That's money the Marlins could have used to hold onto Josh Willingham. The money they saved on injuries could even go toward keeping Dan Uggla in South Florida for a little while longer. It may have even helped the Marlins lock in young ace Josh Johnson into a long-term deal. Seeing how the Marlins are never a big free-agent spender, most of the money saved could go toward keeping their own players. The Big Risk: Anyone remember Alejandro de Aza? How about Chuck Carr? The Marlins have gone most of their franchise's existence without a real center fielder. When they've had one-like a declining Devon White or a rising Juan Pierre-the results have been pretty good. Like World Series ring good. Without them, well, that's when you get this kind of picture. Cameron Maybin could be the piece missing for the Marlins as they try to build around Hanley Ramirez heading into a new stadium. With pressure to spend, a nice John Hart-style contract could be in the offing for a healthy Maybin. Maybin showed flashes of his potential late last season, but he ended 2009 with surgery on his labrum. This is similar to what Hanley Ramirez has gone through, so there's experience here for the team, but it's also similar to what we saw a more similar player have: B.J. Upton. Maybin doesn't have the power upside, so it shouldn't affect him the same way, and despite the Rays having a much better health record, I'll take the Ramirez comp here. The Comeback: Trading Josh Beckett has already worked out pretty well for the Marlins. (The Red Sox didn't do so badly, either.) There might be a clear winner if Anibal Sanchez hadn't had his shoulder shredded. Still, we're seeing that some players are starting to make it back from labrum surgery, and Sanchez could be one of them. He doesn't rely solely on velocity, though that came back some in '09. He's not likely to be the next Chris Carpenter, but he's also still cheap and still has some upside. Time, it seems, is the best healer of labrum tears. It takes two years before we know whether or not a pitcher is still a pitcher. Signs are good for Sanchez, though the risk is still massive. The Trend: The Marlins don't spend much on players, so they can't lose much. In relative terms, they always look good on the dollars, so injury cost is a metric almost built for them. There, they're pretty darn good as well. Days is where they really shine, if by shine you mean "the lower part of mid-pack." They're never bad, but they're never great. Like most of their seasons, they're good enough to be good enough, but they're seldom mentioned with the elite teams or contenders. They're likely to be there again, but how they handle the young, risky pitching staff will determine whether they have a contender when that fancy new ballpark is ready. The Ratings
|
I don't understand the Josh Johnson comment at all. I never considered him, let alone thought he would be good or bad.